Author

Ryan Galasso

Observed institutions: Regulus Therapeutics (United States), University of California, Los Angeles, Bristol-Myers Squibb (United States)

ORCID: 0009-0004-2198-6769

Observed ORCID: 0009-0004-2198-6769

OpenAlex ID: A5104076557

β-Cell Replication Is the Primary Mechanism Subserving the Postnatal Expansion of β-Cell Mass in Humans

2008 · Juris J. Meier, Alexandra E. Butler, et al. · Diabetes · 690

Hyperinsulinemic Hypoglycemia After Gastric Bypass Surgery Is Not Accompanied by Islet Hyperplasia or Increased β-Cell Turnover

2006 · Juris J. Meier, Alexandra E. Butler, et al. · Diabetes Care · 249

Beneficial Endocrine but Adverse Exocrine Effects of Sitagliptin in the Human Islet Amyloid Polypeptide Transgenic Rat Model of Type 2 Diabetes

2009 · Aleksey V. Matveyenko, Sarah Dry, et al. · Diabetes · 242

microRNA-17 family promotes polycystic kidney disease progression through modulation of mitochondrial metabolism

2017 · Sachin Hajarnis, Ronak Lakhia, et al. · Nature Communications · 211

The Antiinflammatory Cytokine Interleukin-1 Receptor Antagonist Protects from High-Fat Diet-Induced Hyperglycemia

2008 · Nadine S. Sauter, Fabienne T. Schulthess, et al. · Endocrinology · 198

Relationship between pancreatic vesicular monoamine transporter 2 (VMAT2) and insulin expression in human pancreas

2008 · Yoshifumi Saisho, Paul E. Harris, et al. · Journal of Molecular Histology · 85

Intrahepatic Transplanted Islets in Humans Secrete Insulin in a Coordinate Pulsatile Manner Directly Into the Liver

2006 · Juris J. Meier, Irene Hong-McAtee, et al. · Diabetes · 43

Ongoing β-Cell Turnover in Adult Nonhuman Primates Is Not Adaptively Increased in Streptozotocin-Induced Diabetes

2011 · Yoshifumi Saisho, Erica Manesso, et al. · Diabetes · 41

CC-99282 is a Novel Cereblon (CRBN) E3 Ligase Modulator (CELMoD) Agent with Enhanced Tumoricidal Activity in Preclinical Models of Lymphoma

2021 · Soraya Carrancio, Lynda Groocock, et al. · Blood · 30

Golcadomide: An Oral CELMoD Agent Targeting IKZF1/3 for Diffuse Large B-cell Lymphoma

2025 · Zhongying Mo, Lynda Groocock, et al. · Blood Cancer Discovery · 5

Abstract 3932: Pathway interaction and mechanistic synergy of CC-99282, a novel cereblon E3 ligase modulator (CELMoD) agent, with enhancer of zeste homolog 2 inhibitors (EZH2is)

2022 · Soraya Carrancio, Celia Fontanillo, et al. · Cancer Research · 3

Supplementary Tables 1-16 from Golcadomide: An Oral CELMoD Agent Targeting IKZF1/3 for Diffuse Large B-cell Lymphoma

2026 · Zhongying Mo, Lynda Groocock, et al.

Data from Golcadomide: An Oral CELMoD Agent Targeting IKZF1/3 for Diffuse Large B-cell Lymphoma

2026 · Zhongying Mo, Lynda Groocock, et al.

Supplementary Figures S1-S16 from Golcadomide: An Oral CELMoD Agent Targeting IKZF1/3 for Diffuse Large B-cell Lymphoma

2026 · Zhongying Mo, Lynda Groocock, et al.

Wydzielanie insuliny w skoordynowany, pulsacyjny sposób bezpośrednio do wątroby przez wyspy trzustkowe przeszczepione do wątroby

2006 · Juris J. Meier, Irene Hong‐McAtee, et al. · Via Medica Journals

Works count: 17

Citation count: 1,797

H-index: 9

I10-index: 9